Eko
United States
- Oakland, California
- 23/03/2022
- Series C
- $30,000,000
Applying machine learning in the fight against heart and lung disease with AI-powered smart stethoscopes.
- Industry Medical Equipment Manufacturing
- Website https://www.ekohealth.com/
- LinkedIn https://www.linkedin.com/company/eko-health/about/
Related People
Connor LandgrafFounder
United States -
Oakland, California
Connor Landgraf is the co-founder and CEO of Eko. Connor founded Eko while studying bioengineering at the University of California, Berkeley, with the goal of improving cardiovascular and pulmonary disease monitoring through machine learning and non-invasive sensors. Eko became the youngest team to receive FDA clearance for a medical device, and Eko technology is used by hundreds of thousands of clinicians to more effectively screen millions of patients around the world for cardiac and pulmonary disease, in-person and through telehealth. Since its founding, Eko has built the world’s largest database for heart sounds and is putting disease detection capabilities with performance comparable to that of an expert cardiologist in any clinician’s stethoscope. Connor was listed as a Forbes 30 under 30 in 2015.
Sycamore Labs | $65,000,000 | (Mar 31, 2026)
Deccan AI | $25,000,000 | (Mar 31, 2026)
Stedi | $50,000,000 | (Mar 31, 2026)
OpenBox AI | $5,000,000 | (Mar 31, 2026)
Qodo | $70,000,000 | (Mar 31, 2026)
Starcloud | $170,000,000 | (Mar 31, 2026)
Valinor(1) | $25,000,000 | (Mar 31, 2026)
Mars Men | $27,500,000 | (Mar 31, 2026)
Scalvy | $13,900,000 | (Mar 27, 2026)
SIGMAS | $1,000,000 | (Mar 27, 2026)
CurrentClient | $1,250,000 | (Mar 27, 2026)
VITL | $7,500,000 | (Mar 27, 2026)